Product Information
TOPIRAMATE 200 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.1098 per EA under NDC 69097012515. Its NADAC has been published 604 times since Jan 28, 2015.
FDA first approved this application on Mar 27, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Cipla USA Inc.NDC
69097012515
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
TOPIRAMATEApproval Type
Generic (ANDA)
FDA Application
ANDA076343FDA Approved
3/27/2009
TE Code
AB
On Market Since
6/12/2014
Pharmacological Classes
Price Statistics
The NADAC for TOPIRAMATE 200 MG TABLET has been published 604 times since Jan 28, 2015, and over the history we have for it it has declined 12.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1098 per EA |
|---|---|
| All-time high | $0.1389 (Jul 15, 2015) |
| All-time low | $0.0880 (Apr 17, 2024) |
| 52-week high | $0.1098 |
| 52-week low | $0.1009 |
| Median price | $0.1106 |
| Average price | $0.1117 |
| Largest weekly change | -19.3% (Apr 17, 2024) |
| Weeks tracked | 604 |
| Tracking since | Jan 28, 2015 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 20% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TOPIRAMATE 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TOPIRAMATE 200 MG TABLET, manufactured by Cipla USA Inc., is $0.1098 per EA (NDC 69097012515), effective Aug 19, 2026.
How has the price of TOPIRAMATE 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for TOPIRAMATE 200 MG TABLET has declined 12.6%. It has been tracked across 604 weekly CMS publications since Jan 28, 2015.
What are the highest and lowest recorded NADAC prices for TOPIRAMATE 200 MG TABLET?
Since Jan 28, 2015, the NADAC for TOPIRAMATE 200 MG TABLET has ranged from a low of $0.0880 (Apr 17, 2024) to a high of $0.1389 (Jul 15, 2015), with a median of $0.1106 per EA.
Are there cheaper alternatives to TOPIRAMATE 200 MG TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TOPIRAMATE 200 MG TABLET, is $0.0880 per EA — about 20% below TOPIRAMATE 200 MG TABLET.
Who manufactures TOPIRAMATE 200 MG TABLET?
TOPIRAMATE 200 MG TABLET (NDC 69097012515) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.